Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons dr. M.V. Lukens

Publicaties

Anti-IFC antibodies in a patient with CHAPLE syndrome: Implications for blood management

Fluctuations in thyroid hormone levels during initial treatment for differentiated thyroid carcinoma are associated with changes in hemostasis: a prospective cohort study

Occurrence of FVIII Inhibitors in Hemophilia A Patients Following an Institutional Switch to a Third Generation B-Domain-Deleted FVIII

Impact of COVID-19 pandemic on the quality of test output in haemostasis laboratories

Optimising the Nadroparin Dose for Thromboprophylaxis During Hemodialysis by Developing a Population Pharmacodynamic Model Using Anti-Xa Levels

Prospective individual patient data meta-analysis of two randomized trials on convalescent plasma for COVID-19 outpatients

Trough anti-Xa activity after intermediate dose nadroparin for thrombosis prophylaxis in critically ill patients with COVID-19 and acute kidney injury

Direct Oral Anticoagulants in Antithrombin Deficiency: Initial Experience in a Single Center

Effect of lower VWF and FXI levels on levonorgestrel IUS and endometrial ablation treatment success in heavy menstrual bleeding: An exploratory study

Genetic testing of hereditary antithrombin deficiency in a large US pedigree using saliva samples

Lees meer